On September 1, 2021 Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, reported that the Company will participate in the following upcoming investor conferences in September (Press release, Chemomab, SEP 1, 2021, View Source [SID1234587139]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 16th Annual BioPharma Virtual Conference
Format: Available for 1-on-1 meetings
Date: September 8-10, 2021
Registration Link
H.C. Wainwright 23rd Annual Global Investment Conference (virtual)
Format: On demand presentation and available for 1-on-1 meetings
Date: September 13-15, 2021
Registration Link
Oppenheimer Fall Healthcare Life Sciences and MedTech Summit (virtual)
Format: Live presentation webcast and available for 1-on-1 meetings
Presentation: September 22, 8:15 am ET
Webcast Link
Cantor Fitzgerald Virtual Global Healthcare Conference
Format: Fireside chat and available for 1-on-1 meetings
Fireside Chat: September 30, 11:20 am ET
Webcast Link
The presentations and archived webcasts will also be accessible in the News and Events section of the Chemomab website.

On September 1, 2021 Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, reported that the Company will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021 (Press release, Lipocine, SEP 1, 2021, https://www.prnewswire.com/news-releases/lipocine-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301366743.html [SID1234587138]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021

Presentation time: September 13, 2021 starting at 7:00 a.m. EST
Webcast link: View Source

A webcast of Lipocine’s presentation will be available on-demand as of 7:00 am ET, Monday, September 13, 2021, thorough the H.C. Wainwright conference portal, on Lipocine’s website under "Events & Presentations" in the Investors section or using the webcast link above. The webcast will be available on the Lipocine’s website for 90 days.

On September 12, 2021 Insmed Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, reported that management will participate in the following virtual investor events (Press release, Insmed, SEP 1, 2021, View Source [SID1234587137]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference on September 8, 2021 at 9:45 a.m. ET in a fireside chat
The Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021 at 3:30 p.m. ET in a fireside chat
The H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021 at 7:00 a.m. ET in a fireside chat available for on-demand viewing
SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event on September 22, 2021 in 1×1 investor meetings
The Cantor Fitzgerald Virtual Global Healthcare Conference on September 27, 2021 at 8:00 a.m. ET in a fireside chat
Each fireside chat will be webcast and can be accessed by visiting the investor relations section of the Company’s website at www.insmed.com. Each webcast will be archived for a period of 30 days following the respective presentation dates.

On September 1, 2021 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following schedule of investor conferences (Press release, Akebia, SEP 1, 2021, View Source [SID1234587134]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference
Virtual fireside chat at 2:45 p.m. ET on September 9

H.C. Wainwright 23rd Annual Global Investment Conference
On-demand presentation available at 7:00 a.m. ET on September 13

Cantor Fitzgerald Virtual Global Healthcare Conference 2021
Virtual presentation at 2:00 p.m. ET on September 27
Where applicable, live webcasts of Akebia’s fireside chats and presentations will be made available on the Investors section of the Company’s website at View Source .

On September 1, 2021 Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, reported Helen Sabzevari, PhD, President and CEO of Precigen, will participate in two upcoming conferences (Press release, Precigen, SEP 1, 2021, https://www.prnewswire.com/news-releases/precigen-to-present-at-the-2021-wells-fargo-virtual-healthcare-conference-and-the-hc-wainwright-23rd-annual-global-investment-conference-301366548.html [SID1234587133]). Dr. Sabzevari will participate in a virtual fireside chat at the 2021 Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021 at 8:40 AM ET, and present at the H.C. Wainwright 23rd Annual Global Investment Conference. The H.C. Wainwright webcast will be available on-demand beginning Monday, September 13, 2021 at 7:00 AM ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Participants may access the webcasts for these events through Precigen’s website in the Press & Events section at investors.precigen.com/events-presentations.